Demographics of Individuals Refusing Cancer Treatment and Reported Pain Compared With Those in Treatment: An Analysis of the 2017-2020 Behavioral Risk Factor Surveillance System
More than 1.6 million people are diagnosed with cancer each year. Despite the different treatment options available for cancer, many individuals refuse treatment for various reasons. However, little is known about the cumulative group of individuals who refuse treatment.
Addressing barriers to clinical trial participation is critical to accelerate progress toward more effective (and less toxic) cancer treatments and provide patients with access to novel treatment approaches. Receiving treatment in a clinical trial is considered by many to be high-quality cancer care; the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology state that “the best management for any cancer patient is in a clinical trial.
The field of oncology has undergone a significant transformation with the emergence of alternative payment models and a growing emphasis on value-based care. The new Enhancing Oncology Model (EOM) has been dubbed “Version 2.0” of the Oncology Care Model (OCM) and presents the potential to optimize patient care, streamline processes through improved coordination, and reduce the overall costs of cancer.
From both a patient and physician standpoint, the discussion of a new cancer diagnosis is both difficult emotionally and necessary to begin devising a plan for treatment and a positive outcome. Following the initial response, many patients will then ask, “Doctor, what is my stage?” While many patients are not familiar with the specifics of cancer staging, more and more patients understand that strategies exist that classify their cancer in order to direct treatment, follow-up, and prediction of outcomes.
Results 1 - 4 of 4